How frequently will the Criteria be reviewed and updated?
Governments recognise the need for the conditions identified and the criteria for the use of IVIg to be regularly reviewed to take account of the evolving processes of disease diagnosis, treatment and outcome evaluation. It is proposed that the Criteria will be reviewed three-yearly, with the review process commencing two years after the release of each new version, allowing 12 months for consultation and drafting.
